Pepdox
Studies
Peptides
Calculator
Phase 3 ESSENCE Trial: Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis. | Pepdox
Home
/
Search
/
PMID 39896971
Phase 3 ESSENCE Trial: Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis.
Gastroenterology & hepatology
2024
PMID: 39896971
View on PubMed
Semaglutide